首页> 中文期刊> 《四川医学》 >布地奈德雾化吸入辅助治疗小儿急性喉炎临床效果探讨

布地奈德雾化吸入辅助治疗小儿急性喉炎临床效果探讨

         

摘要

Objective To study the budesonide aerosol inhalation of auxiliary treatment of children acute laryngitis clinical treatment effect and safety.Methods 62 cases of children with acute laryngitis random divided into observation group and control group,each group of 31 patients,two groups were given the conventional symptomatic treatment group,add a methylprednisolone static drop treatment,observation group add with budesonide suspension of atomization inhalation in the treatment.Two groups of children to observe therapeutic effect,symptoms and signs disappeared time,and observe adverse drug reaction.Results Observation group total effectiveness 96.8%,is significantly better than 61.3% in control group (P < 0.05),the observation group symptoms disappear time are lower than those of the control group (P < 0.05) ; Two groups were no obvious adverse reaction occurred.Conclusion Budesonide aerosol inhalation of auxiliary treatment of children acute laryngitis curative effect is distinct,work fast,safe,reliable and suitable for clinical application.%目的 探讨布地奈德雾化吸入辅助治疗小儿急性喉炎的临床治疗效果及安全性.方法 将62例急性喉炎患儿随机分成观察组与对照组,每组31例,两组均给予常规对症治疗,对照组加用甲泼尼龙静滴治疗,观察组加用布地奈德混悬液雾化吸入治疗.观察两组患儿治疗效果、症状及体征消失时间,并观察药物不良反应.结果 观察组总有效率96.8%,显著优于对照组的61.3% (P<0.05),观察组症状消失时间均低于对照组(P均<0.05);两组均无明显不良反应发生.结论布地奈德雾化吸入辅助治疗小儿急性喉炎疗效显著,起效快,安全可靠,适合临床推广应用.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号